| Log in

Evolvence Life Sciences Fund Invests Rs 35 Cr in Sutures India

02 September, 2009

Evolvence India Life Sciences Fund (EILSF) has invested upto Rs 35 crore in Sutures India Private Limited, a company specializing in the manufacture of surgical consumables. The company is involved in manufacturing a range of wound closure products such as natural and synthetic absorbable and non-absorbable sutures, surgical needles, staples, tapes, hernia meshes, and disposable surgical gloves.

Vishy Chibrolu, managing director with Evolvence India Life Sciences Fund, will be joining the board of the company.

The Bangalore-based firm also exports to over 50 countries in regions like Europe, South America, Africa and Asia. The market for sutures only is said to be at $250 million in India, Brazil and Russia combined, and $3-4 billion world over. Around 30-40% of the revenues come from the export market, while the rest are from domestic market.

“The company has a nationwide distribution network. Primarily the focus for the company is around tier 2, 3 and rural markets,” said Chibrolu in an interview to VCCircle. Sutures India has a market share 15-20% in India, and is second largest producer in the country after Johnson & Johnson .

The funds will be partly used for expansion, and partly for working capital requirements. Sutures will also look at inorganic growth opportunities.

EILSF is picking up the pace of its investments. The life sciences focused fund announced an investment of Rs 25 crore in Chennai based Anjan Drugs, one of the largest US-FDA approved manufacturers of drugs for epilepsy, in June. Sutures is its fourth investment, other two being advanced drug delivery mechanism company Gland Pharma and cancer centre network, Health Care Global.


Leave Your Comment
Exclusive: CX Partners’ next move in Sutures India

Exclusive: CX Partners’ next move in Sutures India

Debjyoti Roy 2 years ago
India-focused private equity firm CX Partners is all set to sell its remaining...
TPG Growth raises stake in Bangalore-based Sutures India to 46%

TPG Growth raises stake in Bangalore-based Sutures India to 46%

Anuradha Verma 3 years ago
TPG Growth, the mid-market and growth equity platform of alternatives major TPG...
TPG Growth picks stake in Sutures for $23.6M, eyes control deals in healthcare space

TPG Growth picks stake in Sutures for $23.6M, eyes control deals in healthcare space

Lohit Jagwani 4 years ago
TPG Growth, the mid-market and growth equity platform of alternatives major TPG,...
No Comments

Evolvence Life Sciences Fund Invests Rs 35 Cr in Sutures India

Powered by WordPress.com VIP